First Bancorp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$256K Buy
1,715
+15
+0.9% +$2.1K 0.1% 120
2026
Q2
$215K Hold
1,700
– – 0.08% 137
2026
Q1
$237K Hold
1,700
– – 0.12% 119
2025
Q4
$209K Buy
+1,700
New +$207K 0.11% 124
2023
Q1
– Sell
-2,460
Closed -$211K – 113
2022
Q4
$211K Buy
+2,460
New +$195K 0.18% 109

Other funds holding GILD

First Bancorp's GILD Position: Q3 2026 in Review

First Bancorp increased its Gilead Sciences (GILD) stake by 0.88% in Q3 2026, buying an estimated $2.1K and bringing the position to 1,715 shares worth $256K. The position accounts for 0.1% of the portfolio, ranked #120.

First Bancorp first reported a position in GILD in Q4 2022 and has held it in 5 quarters since. 976 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • First Bancorp held 1,715 shares of Gilead Sciences worth $256K as of Q3 2026.
  • First Bancorp bought 15 Gilead Sciences shares in Q3 2026, an estimated $2.1K.
  • Gilead Sciences made up 0.1% of First Bancorp's portfolio in Q3 2026, its #120 holding.
  • First Bancorp first reported a position in Gilead Sciences in Q4 2022 and has held it in 5 quarters since.
  • 976 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on First Bancorp's 13F filing for Q3 2026, filed 26 Oct 2026.